-
2
-
-
33748538992
-
Targeted inhibition of phospho-inositide 3-kinase activity as a novel strategy to normalize beta-adrenergic receptor function in heart failure
-
Perrino C, Rockman HA, Chiariello M. Targeted inhibition of phospho-inositide 3-kinase activity as a novel strategy to normalize beta-adrenergic receptor function in heart failure. Vascul Pharmacol. 2006; 45:77-85.
-
(2006)
Vascul Pharmacol
, vol.45
, pp. 77-85
-
-
Perrino, C.1
Rockman, H.A.2
Chiariello, M.3
-
3
-
-
0035853147
-
Cardiac overexpression of a G(q)inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload
-
Esposito G, Prasad SV, Rapacciuolo A, Mao L, Koch WJ, Rockman HA. Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload. Circulation. 2001;103:1453-1458.
-
(2001)
Circulation
, vol.103
, pp. 1453-1458
-
-
Esposito, G.1
Prasad, S.V.2
Rapacciuolo, A.3
Mao, L.4
Koch, W.J.5
Rockman, H.A.6
-
4
-
-
0027418496
-
Transcriptional regulation during cardiac growth and development
-
Chien KR, Zhu H, Knowlton KU, Miller-Hance W, van-Bilsen M, O'Brien TX, Evans SM. Transcriptional regulation during cardiac growth and development. Annu Rev Physiol. 1993;55:77-95. (Pubitemid 23102124)
-
(1993)
Annual Review of Physiology
, vol.55
, pp. 77-95
-
-
Chien, K.R.1
Zhu, H.2
Knowlton, K.U.3
Miller-Hance, W.4
Van-Bilsen, M.5
O'Brien, T.X.6
Evans, S.M.7
-
5
-
-
0022484034
-
Extra-atrial expression of the gene for atrial natriuretic factor
-
Gardner DG, Deschepper CF, Ganong WF, Hane S, Fiddes J, Baxter JD, Lewicki J. Extra-atrial expression of the gene for atrial natriuretic factor. Proc Natl Acad Sci U S A. 1986;83:6697-6701.
-
(1986)
Proc Natl Acad Sci U S A
, vol.83
, pp. 6697-6701
-
-
Gardner, D.G.1
Deschepper, C.F.2
Ganong, W.F.3
Hane, S.4
Fiddes, J.5
Baxter, J.D.6
Lewicki, J.7
-
6
-
-
33745185351
-
Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction
-
Perrino C, Naga Prasad SV, Mao L, Noma T, Yan Z, Kim HS, Smithies O, Rockman HA. Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. J Clin Invest. 2006;116:1547-1560.
-
(2006)
J Clin Invest
, vol.116
, pp. 1547-1560
-
-
Perrino, C.1
Naga Prasad, S.V.2
Mao, L.3
Noma, T.4
Yan, Z.5
Kim, H.S.6
Smithies, O.7
Rockman, H.A.8
-
7
-
-
0025311528
-
Peripheral adrenergic receptors in hypertension
-
Michel MC, Brodde OE, Insel PA. Peripheral adrenergic receptors in hypertension. Hypertension. 1990;16:107-120.
-
(1990)
Hypertension
, vol.16
, pp. 107-120
-
-
Michel, M.C.1
Brodde, O.E.2
Insel, P.A.3
-
8
-
-
0025873338
-
Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy
-
Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J Jr, Chien KR. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci U S A. 1991;88: 8277-8281.
-
(1991)
Proc Natl Acad Sci U S A
, vol.88
, pp. 8277-8281
-
-
Rockman, H.A.1
Ross, R.S.2
Harris, A.N.3
Knowlton, K.U.4
Steinhelper, M.E.5
Field, L.J.6
Jr, R.J.7
Chien, K.R.8
-
9
-
-
3042833801
-
Genetic factors in cardiac hypertrophy
-
Dorn GW II, Hahn HS. Genetic factors in cardiac hypertrophy. Ann N Y Acad Sci. 2004;1015:225-237.
-
(2004)
Ann N y Acad Sci
, vol.1015
, pp. 225-237
-
-
Dorn Ii, G.W.1
Hahn, H.S.2
-
10
-
-
34248591612
-
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
-
Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26: 3291-3310.
-
(2007)
Oncogene
, vol.26
, pp. 3291-3310
-
-
Roberts, P.J.1
Der, C.J.2
-
11
-
-
34548858159
-
Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease
-
Clark JE, Sarafraz N, Marber MS. Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease. Pharmacol Ther. 2007;116: 192-206.
-
(2007)
Pharmacol Ther
, vol.116
, pp. 192-206
-
-
Clark, J.E.1
Sarafraz, N.2
Marber, M.S.3
-
13
-
-
33646034318
-
JNK1 is required to preserve cardiac function in the early response to pressure overload
-
Tachibana H, Perrino C, Takaoka H, Davis RJ, Naga Prasad SV, Rockman HA. JNK1 is required to preserve cardiac function in the early response to pressure overload. Biochem Biophys Res Commun. 2006;343: 1060-1066.
-
(2006)
Biochem Biophys Res Commun
, vol.343
, pp. 1060-1066
-
-
Tachibana, H.1
Perrino, C.2
Takaoka, H.3
Davis, R.J.4
Naga Prasad, S.V.5
Rockman, H.A.6
-
14
-
-
2542478761
-
Transient and reversible deoxyribonucleic acid damage in human left ventricle under controlled ischemia and reperfusion
-
Corbucci GG, Perrino C, Donato G, Ricchi A, Lettieri B, Troncone G, Indolfi C, Chiariello M, Avvedimento EV. Transient and reversible deoxyribonucleic acid damage in human left ventricle under controlled ischemia and reperfusion. J Am Coll Cardiol. 2004;43:1992-1999.
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 1992-1999
-
-
Corbucci, G.G.1
Perrino, C.2
Donato, G.3
Ricchi, A.4
Lettieri, B.5
Troncone, G.6
Indolfi, C.7
Chiariello, M.8
Avvedimento, E.V.9
|